"The Staging Option and Drug Development" by Neal A. Lewis

Article

The Staging Option and Drug Development

Pharmaceutical Engineering

Neal A. Lewis
David Lee Enke, Missouri University of Science and Technology
David Spurlock, Missouri University of Science and Technology

Abstract

This article investigates the staging option to analyze an existing case study that involves the potential licensing of a drug compound that is in development. It demonstrates how options analysis is a useful tool in adding insight to the decision making process when conventional valuation methods are not decisive.

Department(s)

Engineering Management and Systems Engineering

Keywords and Phrases

Cost Benefit Analysis,
Decision Making,
Depression,
Drug Formulation,
Drug Industry,
Financial Management,
Licensing,
Mathematics,
Review,
Staging,
Weight Reduction

Document Type

Article - Journal

Document Version

Citation

File Type

text

Language(s)

English

Rights

Publication Date

11-1-2005

Publication Date

01 Nov 2005

Disciplines

Operations Research, Systems Engineering and Industrial Engineering

Citation Information

Neal A. Lewis, David Lee Enke and David Spurlock. "The Staging Option and Drug Development" Pharmaceutical Engineering Vol. 25 Iss. 6 (2005) p. 58-66+76-78 - 58 ISSN: 0273-8139
Available at: http://works.bepress.com/david-enke/52/